Livzon Pharmaceutical Group's total assets for Q2 2025 were ¥24.17B, a decrease of -1.28% from the previous quarter. HK:1513 total liabilities were ¥9.25B for the fiscal quarter, a 1.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.